The Miami Nature Biotechnology Winter Symposia

October 16, 1997

The University of Miami and Nature Publishing Company are sponsoring the 30th annual Miami Nature Biotechnology Winter Symposia. Research topics include basic science and genetic research on diseases such as cancer, diabetes, transplantation, muscular distrophy, and Alzheimer's disease. More information on the symposia can be found at


Deadline November 3, 1997

Short Reports for poster presentation of exceptional interest may be selected for 15 minute oral presentation within the program. Short Reports will be published as Volume 9 of the Miami Nature Biotechnology Short Reports, by IRL Press at Oxford University Press as part of their Nucleic Acids Symposium Series.

The Miami Nature Biotechnology Winter Symposia
Advances in Gene Technology: Molecular Biology in the Conquest of Disease
February 7-11, 1998
Hyatt Regency Hotel, Miami, Florida, U.S.A.

Topics: Speakers: P. Aebischer, A. Bairoch, F. Bach, D.J. Baylink, G.I. Bell, F.R. Blattner, C. Bordignon, M.B. Bunge, M.R. Capecchi, C.T. Caskey, J. Folkman, T. Gaasterland, P. Gruss, E.P. Hoffman, R. Jaenisch, P.H. Krammer, H. Lehrach, D.J. Lockhart, C. Ricordi, A.D. Roses, P.R. Sanberg, C. Sander, O. Smithies, P.K. Srivastava, R.I. Tepper, S. Tonegawa, C. Weissmann, and H.F. Willard

This is a CME credit (23.5 hours) activity of the University of Miami School of Medicine

Instructions for preparing Short Reports for poster presentation along with the full program and registration information can be found on the web at or you can call 1-305-243-3597, fax 1-305-324-5665 or email (or use the coupon below)

Posters received after the deadline of November 3, 1997, will be considered for presentation in the posters sessions but will not be published in the proceedings. Copies are distributed at the meeting as additional poster presentations.

Sponsored by the University of Miami and Nature Publishing Company Orgainzed by the University Biochemistry & Molecular Biology Foundation, Inc. and Nature Biotechnology

Major Supporters: Boehringer Mannheim Biochemicals, Coulter Corporation, Warner-Lambert, Parke Davis Pharmaceuticals, and Glaxo-Wellcome Research and Development

To receive a program and poster information fill in this coupon and fax it (1-305-324-5665) or mail it (MNBWS, PO Box 016129, M823, Miami, Fl. 33101, USA)
Business Address___________________________________

University of Miami

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to